Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

被引：0
|
作者：
Dan Călugăru
Mihai Călugăru
机构：
[1] University of Medicine Cluj-Napoca/Romania,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 235
页数：2
相关论文
共 50 条
  • [41] Photodynamic Therapy With or Without Intravitreal Triamcinolone Acetonide for Symptomatic Polypoidal Choroidal Vasculopathy
    Lai, Timothy Y. Y.
    Lam, Carol P. S.
    Luk, Fiona O. J.
    Chan, Rose P. S.
    Chan, Wai-Man
    Liu, David T. L.
    Lam, Dennis S. C.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (01) : 91 - 95
  • [42] INTRAVITREAL AFLIBERCEPT WITH AND WITHOUT RESCUE PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY: 2-YEAR RESULTS OF THE PLANET STUDY
    Ao, Paul Mitchell
    Iida, Tomohiro
    Ogura, Yuichiro
    Chen, Shih Jen
    Wong, Tien Yin
    Zhang, Eric
    Leal, Sergio
    Ishibashi, Tatsuro
    Cheung, Gemmy
    Lee, Won Ki
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 127 - 128
  • [43] 2-Year Results of the PLANET Study: Intravitreal Aflibercept Alone and With Rescue Photodynamic Therapy in Polypoidal Choroidal Vasculopathy
    Lee, Won Ki
    Ogura, Yuichiro
    Iida, Tomohiro
    Chen, Shih-Jen
    Wong, Tien Yin
    Mitchell, Paul
    Qiu, Jeannie
    Leal, Sergio
    Ishibashi, Tatsuro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [44] Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection
    Japanese Journal of Ophthalmology, 2017, 61 : 204 - 205
  • [45] Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection
    Saito, Masaaki
    Kano, Mariko
    Itagaki, Kanako
    Ise, Shigeyuki
    Imaizumi, Kimihiro
    Sekiryu, Tetsuju
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2016, 60 (01) : 35 - 41
  • [46] Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection
    Uzun, Salih
    Pehlivan, Emre
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (02) : 204 - 205
  • [47] Analysis of Efficacy of Intravitreal Aflibercept According to Subfoveal Choroidal Thickness in Polypoidal Choroidal Vasculopathy
    Lee, Donghun
    Jeong, Seongyong
    Moon, Jongwon
    Lee, Junyeop
    Sagong, Min
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (10): : 1577 - 1585
  • [48] Treatment of Polypoidal Choroidal Vasculopathy With Photodynamic Therapy Combined With Intravitreal Injections of Ranibizumab
    Tomita, Kaoruko
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Ooto, Sotaro
    Tamura, Hiroshi
    Otani, Atsushi
    Nakayama, Yoshihito
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (01) : 68 - 80
  • [49] Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection
    Masaaki Saito
    Mariko Kano
    Kanako Itagaki
    Shigeyuki Ise
    Kimihiro Imaizumi
    Tetsuju Sekiryu
    Japanese Journal of Ophthalmology, 2016, 60 : 35 - 41
  • [50] Infographic: “Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)”
    Shaun Sebastian Sim
    Chinmayi Himanshuroy Vyas
    Rubamalar Gunatheesan
    Pooi Wah Lott
    Christopher Ziyu Sun
    Kelvin Yi Chong Teo
    Chui Ming Gemmy Cheung
    Eye, 2022, 36 : 1142 - 1142
12345